Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction. MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, announced a $63.5 million Series...
MBX Biosciences’ $63.5 Million Series C Financing Round
MBX Biosciences’ $115 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management. MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision...